Cytembena and cis-platinum in combination for advanced stage ovarian carcinoma treatment.
D000179:Acrylates / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002277:Carcinoma / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003536:Cystadenocarcinoma / Q000188:drug therapy; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D000179:Acrylates; D000970:Antineoplastic Agents; D004317:Doxorubicin; D003520:Cyclophosphamide; C100245:bromebric acid; D002945:Cisplatin